Geovax Labs Inc (NAS:GOVXW)
$ 0.0599 -0.0001 (-0.17%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 75.65 GF Score: 48/100

Q3 2022 GeoVax Labs Inc Earnings Call Transcript

Nov 09, 2022 / 09:30PM GMT
Operator

Good afternoon, and welcome, everyone, to the GeoVax third-quarter 2022 corporate update call. My name is Rob, and I'll facilitate today's call. With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Mark Newman, PhD, Chief Scientific Officer; Kelly McKee, MD, MPH, Chief Medical Officer; and John Sharkey, PhD, Vice President, Business Development. (Operator Instructions)

As a reminder, this conference is being recorded. And at this time, I'm turning the call over to Gaby DeGravina of CG Capital.

Gaby DeGravina
CG Capital - IR

Thank you. Please note the following.

Certain statements in this presentation may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether GeoVax can develop and manufacture its vaccines with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot